# A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo

> **NCT00365924** · NA · COMPLETED · sponsor: **Pfizer** · enrollment: 20 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Forteo

## Key facts

- **NCT ID:** NCT00365924
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00365924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00365924, "A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00365924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*